Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

NRSN

NeuroSense Therapeutics Ltd.

CIK 0001875091 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$0.72
↑ 0.01 (1.59%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Fundamentals, Ownership; Risks: Technicals; Excluded: Options (no data)

Key stats

Market Cap
$23.07M
P/E Ratio
-1.61
EPS
-0.44
Dividend Yield
Not covered
52W Position
6%
Beta
1.23

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
-14.79
P/S
Not covered
EV/Revenue
Not covered
ROE
713.1%
Valuation data covers 8,497/9,463 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 6%
$0.63$2.18

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$11.13M
Total Assets
$1.03M
Free Cash Flow
-$7.68M

Recent news